General anaesthesia is patient-friendly in opioid antagonist detoxification treatment

Addiction

Volumn 100, Issue 11, 2005, Pages 1742-1744

  De Jong, Catherine J ^a  

^a Anaesthesiologist and Intensive Care Specialist   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE ANTAGONIST;

ABSTINENCE; COST BENEFIT ANALYSIS; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; LETTER; OPIATE ADDICTION; OUTCOMES RESEARCH;

ANESTHESIA, GENERAL; ANXIETY; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS;

EID: 27744502820     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.01267.x     Document Type: Letter

References (3)

1. De Jong, C. A., Laheij, R. J. F. & Krabbe, P. F. M. (2005) General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial. Addiction, 100, 206-215.
2. Cowling, L., Ali, R. & White, J. (2002) Opioid antagonist under heavy sedation or anaesthesia for opioid withdrawal (Cochrane Review). The Cochrane Library, Issue 4.
3. Cowling, L., Farrell, M., Ali, R. & White, J. (2003) Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Systematic Review, 2, CD002024.